How much is Tes Pharma worth in 2025?

Tes Pharma has a current valuation of N/A based on their Secondary Transaction - Private round and secondary market data.

How much funding has Tes Pharma raised?

Tes Pharma has raised $53.4M in total funding across 0 funding rounds.

Tes Pharma

Website

Last updated: N/A

Current Valuation

N/A

Total Funding Raised

$53.4M

Last Round

Secondary Transaction - Private

Amount undisclosed

Last Funding

Unknown

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Tes Pharma is currently valued at N/A. The company has raised a total of $53.4M in funding.

Investment Perspective

Tes Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Tes Pharma Valuation Updates

Get notified when Tes Pharma raises new funding or valuation changes

Explore More Data

Detailed analysis for Tes Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is Tes Pharma Worth in 2025?

As of 2025, Tes Pharma is valued at N/A. This valuation positions Tes Pharma as one of the leading private companies in the sector.

Tes Pharma Valuation History

Tes Pharma's funding history demonstrates steady growth and investor confidence.

How Tes Pharma Valuation is Determined

Private company valuations like Tes Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

Revenue growth and financial performance
Market opportunity and total addressable market (TAM)
Competitive positioning and market share
Management team strength and execution capability
Technology and intellectual property
Industry trends and investor sentiment

Tes Pharma Valuation FAQs

Is Tes Pharma profitable?

Tes Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Tes Pharma's valuation compare to competitors?

Tes Pharma is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Tes Pharma IPO?

Tes Pharma has not announced plans for an initial public offering. Until an IPO, investors can access Tes Pharma shares through secondary market platforms.